TUESDAY, Feb. 18, 2025 (HealthDay News) -- Federal funding for medical research has dropped by roughly $1 billion this year, ...

Co-authored by Sandro Galea, M.D., and Nason Maani, Ph.D.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The company has created a novel microstructured catheter that has been validated to improve outcomes for stroke patients. Its patent-pending platform, called TRAP, or thrombus retrieval aspiration ...